RankAlpha logo
Back to Rankings

SUPN

SupernusB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SUPN vs peer average
56/100
SUPN vs. peer average (B vs. B)
Grade spread
A 3 · B 3 · C 4 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ACAD is the first available peer comparator.

CNS-focused specialty pharma with marketed neuropsychiatric products and similar commercialization dynamics.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerACADACADIA
SUPN
Supernus
ACAD
ACADIA
Grade
B
C
Momentum
29
27
Value
60
62
Sentiment
88
75
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs ACAD

SUPN / ACAD
Grade Position
In line
SUPN vs. peer average (B vs. B)
56/100
Momentum
29
SUPN
Value
60
ACAD
Sentiment
88
SUPN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SUPN
1
ACAD
ACAD
C
60/100
+1
2
ALKS
ALKS
A
100/100
-1
3
INDV
INDV
A
100/100
-1
4
ALMS
Alumis Inc Common
A
100/100
-1
5
GRAL
GRAIL Inc Common
B
80/100
Even
ACAD is the first peer returned for this comparison set.